GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eco Animal Health Group PLC (LSE:EAH) » Definitions » EV-to-Revenue

Eco Animal Health Group (LSE:EAH) EV-to-Revenue : 0.53 (As of Apr. 25, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Eco Animal Health Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eco Animal Health Group's enterprise value is £47.24 Mil. Eco Animal Health Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £88.46 Mil. Therefore, Eco Animal Health Group's EV-to-Revenue for today is 0.53.

The historical rank and industry rank for Eco Animal Health Group's EV-to-Revenue or its related term are showing as below:

LSE:EAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.63   Med: 3.33   Max: 6.86
Current: 0.53

During the past 13 years, the highest EV-to-Revenue of Eco Animal Health Group was 6.86. The lowest was 0.63. And the median was 3.33.

LSE:EAH's EV-to-Revenue is ranked better than
90.93% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs LSE:EAH: 0.53

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Eco Animal Health Group's stock price is £0.94. Eco Animal Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £1.29. Therefore, Eco Animal Health Group's PS Ratio for today is 0.73.


Eco Animal Health Group EV-to-Revenue Historical Data

The historical data trend for Eco Animal Health Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eco Animal Health Group EV-to-Revenue Chart

Eco Animal Health Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.26 2.03 2.02 1.33 0.71

Eco Animal Health Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.33 - 0.71 -

Competitive Comparison of Eco Animal Health Group's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eco Animal Health Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eco Animal Health Group's EV-to-Revenue falls into.



Eco Animal Health Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Eco Animal Health Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=47.241/88.461
=0.53

Eco Animal Health Group's current Enterprise Value is £47.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eco Animal Health Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £88.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eco Animal Health Group  (LSE:EAH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Eco Animal Health Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.94/1.29
=0.73

Eco Animal Health Group's share price for today is £0.94.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was £1.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eco Animal Health Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eco Animal Health Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eco Animal Health Group (LSE:EAH) Business Description

Traded in Other Exchanges
N/A
Address
78 Coombe Road, New Malden, London, Surrey, GBR, KT3 4QS
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.

Eco Animal Health Group (LSE:EAH) Headlines

No Headlines